143 related articles for article (PubMed ID: 9541334)
61. Critical issues in the treatment of schizophrenia.
Gaebel W
Int Clin Psychopharmacol; 1998 Mar; 13 Suppl 3():S1-6. PubMed ID: 9690963
[TBL] [Abstract][Full Text] [Related]
62. [Augmented antipsychotic therapy with pantogam active in patients with schizophrenia].
Medvedev VE; Frolova VI; Gushanskaya EV; Ter-Israelyan AU
Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(8):28-34. PubMed ID: 26356612
[TBL] [Abstract][Full Text] [Related]
63. Update in the treatment of schizophrenia.
Katz I; Kac M
Aust Fam Physician; 1993 Apr; 22(4):577-80, 584-5, 590-7. PubMed ID: 8481123
[TBL] [Abstract][Full Text] [Related]
64. The content and context of compliance.
Bebbington PE
Int Clin Psychopharmacol; 1995 Jan; 9 Suppl 5():41-50. PubMed ID: 7622833
[TBL] [Abstract][Full Text] [Related]
65. Therapeutic drug monitoring of clozapine in Indian patients with schizophrenia - Authors response.
Suhas S; Kumar V; Venkatasubramanian G
Schizophr Res; 2021 Mar; 229():25-26. PubMed ID: 33609987
[No Abstract] [Full Text] [Related]
66. Schizophrenia: opportunities to improve outcomes and reduce economic burden through managed care.
Wander C
Am J Manag Care; 2020 Mar; 26(3 Suppl):S62-S68. PubMed ID: 32282176
[TBL] [Abstract][Full Text] [Related]
67. A two-year prospective study of treatment compliance in patients with schizophrenia.
Buchanan A
Psychol Med; 1992 Aug; 22(3):787-97. PubMed ID: 1357703
[TBL] [Abstract][Full Text] [Related]
68. Does the evidence now suggest we can safely reduce the frequency of haematological monitoring for patients stabilised on clozapine?
Fanshawe JB; Lennox BR
Lancet Psychiatry; 2024 Jun; 11(6):400-402. PubMed ID: 38697179
[No Abstract] [Full Text] [Related]
69. From noncompliance to collaboration in the treatment of schizophrenia.
Corrigan PW; Liberman RP; Engel JD
Hosp Community Psychiatry; 1990 Nov; 41(11):1203-11. PubMed ID: 1979044
[TBL] [Abstract][Full Text] [Related]
70. What can we achieve by implementing a compliance-improvement program?
Kane JM
Int Clin Psychopharmacol; 1997 Feb; 12 Suppl 1():S43-6. PubMed ID: 9179643
[TBL] [Abstract][Full Text] [Related]
71. Cognitive effects of antipsychotics in schizophrenia and relationship to quality of life.
Kaiser W
Br J Psychiatry; 2000 Jan; 176():92-3. PubMed ID: 10789338
[No Abstract] [Full Text] [Related]
72. Drug compliance in pediatrics. Clinical and research issues.
Matsui DM
Pediatr Clin North Am; 1997 Feb; 44(1):1-14. PubMed ID: 9057780
[TBL] [Abstract][Full Text] [Related]
73. The treatment of schizophrenia: making it work.
Harv Ment Health Lett; 2007 Jun; 23(12):4-6. PubMed ID: 17657890
[No Abstract] [Full Text] [Related]
74. Cognitive enhancement in schizophrenia by buspirone: Role of serotonin
Sumiyoshi T
Schizophr Res; 2020 Jan; 215():455-456. PubMed ID: 31648843
[No Abstract] [Full Text] [Related]
75. Revisiting the 'self-medication' hypothesis in light of the new data linking low striatal dopamine to comorbid addictive behavior.
Awad AG; Voruganti LL
Ther Adv Psychopharmacol; 2015 Jun; 5(3):172-8. PubMed ID: 26199720
[TBL] [Abstract][Full Text] [Related]
76. [Periodic schizophrenia].
GIANNINI A; DEL CARLO GIANNINI G
Rass Studi Psichiatr; 1959; 48(1):73-106. PubMed ID: 13658447
[No Abstract] [Full Text] [Related]
77. Non-compliance with clozapine? Delusional system.
Sloan D; Boyle O
Eur Psychiatry; 1997; 12(2):104. PubMed ID: 19698514
[No Abstract] [Full Text] [Related]
78. Factors associated with medication interruption among outpatients with severe mental illness exposed to COVID-19.
Jiao J; Ji Y; Ren H; Hao Y; Shen X; Dong Z
Front Public Health; 2023; 11():1086863. PubMed ID: 37056653
[TBL] [Abstract][Full Text] [Related]
79. Long Acting Injectable Antipsychotics in the Treatment of Schizophrenia and Bipolar Disorder.
Devrımcı Özgüven H; Kir Y
Noro Psikiyatr Ars; 2021; 58(Suppl 1):S47-S52. PubMed ID: 34658635
[TBL] [Abstract][Full Text] [Related]
80. Predicting pharmacokinetic stability by multiple oral administration of atypical antipsychotics.
Wakamatsu A; Aoki K; Sakiyama Y; Ohnishi T; Sugita M
Innov Clin Neurosci; 2013 Mar; 10(3):23-30. PubMed ID: 23630647
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
